Gene: A0A8J0SCI2 (Xenopus tropicalis, NCBITaxon:8364)
Description (UniProt): "Gastrula zinc finger protein XlCGF17.1-like," 265 aa
Focus type: computational_prediction
Prediction under evaluation: ProtNLM2 → GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
The ProtNLM2 prediction of GO:0001228 (an activator-specific molecular-function term) for A0A8J0SCI2 is REFUTED as over-annotation. The protein is a bare tandem array of eight canonical C2H2 zinc fingers joined by six canonical TGEKP linkers, with no accessory effector domain of any kind — no KRAB, no BTB/POZ, no SCAN, no acidic activation domain. Both sequence-level domain databases (InterPro, Pfam, PANTHER) and the AlphaFold structural model agree: the only recognizable, folded module is the zinc-finger array itself. Because a C2H2 array encodes DNA sequence specificity rather than regulatory direction, whether this factor activates or represses its targets cannot be inferred from its sequence.
The distinction matters for curation because GO:0001228 is a directional child of the direction-neutral term GO:0000981 (DNA-binding transcription factor activity, RNA polymerase II-specific). The existing curated (phylogenetic, IBA) annotations for this gene deliberately stop at the neutral parent GO:0000981; the ProtNLM2 activator call adds a directional constraint that the evidence cannot support. In vertebrates, C2H2-zinc-finger proteins are, if anything, biased toward repression (KRAB-ZNFs are the largest vertebrate repressor family), so "activator" is not even the more probable default. This makes the prediction a textbook example of over-specific, likely paralog- or frequency-transferred labeling.
The most important caveat is that A0A8J0SCI2 is experimentally uncharacterized: there is no reporter assay, ChIP, mutant, or interaction data for this specific protein. The negative judgment therefore rests on domain architecture, structural prediction, GO ontology structure, and the well-established principle that a naked zinc-finger array is directionally uninformative. The protein remains a legitimate candidate sequence-specific RNA Pol II transcription factor — it is simply not demonstrably an activator, and the safest curation position is to retain the neutral GO:0000981 and withhold GO:0001228.
Direct sequence and domain analysis of A0A8J0SCI2 (265 aa) identified eight canonical C2H2 zinc fingers spanning residues ~37–260, joined by six canonical TGEKP inter-finger linkers — the textbook signature of a sequence-specific DNA-binding tandem zinc-finger protein. Domain databases are unanimous and report only zinc-finger content: InterPro IPR013087 (C2H2-type zinc finger) and IPR036236 (zinc finger C2H2 superfamily), Pfam PF00096 (zf-C2H2, five hits), and PANTHER PTHR24381:SF440. Critically, no accessory effector domain was detected by any resource.
The N-terminal region preceding the first finger is only 36 residues long, of which residues 1–27 are predicted disordered. This is far too short to host any of the effector modules that would license a directional call: a KRAB domain is ~75 aa, and BTB/POZ and SCAN domains are larger still. The protein is also not acidic — the aspartate+glutamate fraction is only 9.8% — providing no evidence for an acidic activation domain (classic acidic activation domains are markedly enriched in D/E). In short, the molecule is effector-less.
The mechanistic logic here is decisive. As summarized in the current C2H2 recognition-code literature, "the established C2H2-ZF 'recognition code' suggests that residues at positions −1, −4, and −7 recognize the 5′, central, and 3′ bases of a DNA base-pair triplet, respectively" (PMID: 38754172). That is, the finger array specifies which DNA sequence is bound — it does not encode whether the bound factor will up- or down-regulate transcription. Direction is supplied by separate effector domains and the co-regulators they recruit, which this protein lacks. Furthermore, for the great majority of these proteins the basic facts are unknown: "for most C2H2-ZF proteins it is unknown whether they even bind DNA or, if they do, to which sequences" (PMID: 25690854). An activator-specific claim for an uncharacterized member is therefore unsupported on its face.
The GO annotations already attached to A0A8J0SCI2 in UniProt are all phylogenetically inferred (IBA, GO_Central) or keyword-inferred (IEA), and they deliberately stop at the direction-neutral level:
The ProtNLM2-predicted GO:0001228 is a child of GO:0000981 that adds the directional (activator) constraint. The phylogenetic curators — who had the same orthology evidence available — chose the neutral parent, indicating that the community-standard evidence supports "sequence-specific RNA Pol II transcription factor," and no more. The ProtNLM2 activator call therefore does not merely restate curated knowledge; it over-reaches beyond it.
The AlphaFold DB model AF-A0A8J0SCI2-F1 (v6) (265 residues, global pLDDT 82.4) was analyzed region by region:
| Region | Residues | Mean pLDDT | % residues > 70 | Interpretation |
|---|---|---|---|---|
| N-terminus | 1–36 | 36.8 | 3% | Disordered |
| Zinc-finger core | 37–260 | 90.6 | 99% | Confidently folded |
| C-terminus | 261–265 | 43.4 | — | Disordered |
The confidently folded portion coincides exactly with the eight annotated C2H2 domains. The flanking regions that would have to host a transactivation or transrepression module are unstructured. Structurally, then, there is no folded effector domain — consistent with the sequence analysis in Finding 1 and reinforcing that direction cannot be assigned. Intrinsic disorder does not by itself rule out a function, but there is no positive evidence — sequence composition, motif, or otherwise — for an activation domain within these short disordered tails.
A QuickGO ontology query confirms the term relationships:
is_a-ancestors = {GO:0000981, GO:0003700, GO:0140110, GO:0001216, GO:0003674}Definitions make the added constraint explicit:
| Term | Definition (abridged) | Directionality |
|---|---|---|
| GO:0000981 | "…that modulates the transcription of specific gene sets transcribed by RNA polymerase II" | Neutral |
| GO:0001228 | "…that activates or increases transcription…" | Activator |
| GO:0001227 (sibling) | "…that represses or decreases transcription…" | Repressor |
Moving from GO:0000981 to GO:0001228 therefore adds precisely the claim — activation — that the sequence and structure evidence cannot support, and it does so while an equally specific sibling (GO:0001227, repressor) is a priori at least as plausible for a vertebrate C2H2-ZF protein.
The core issue is a mismatch between what a zinc-finger array can tell us and what the predicted GO term asserts.
A0A8J0SCI2 (265 aa)
┌──────────┬───────────────────────────────────────────────┬──────┐
│ N-term │ 8× C2H2 zinc fingers (res ~37–260) │ C-t │
│ 1–36 │ ZF1–TGEKP–ZF2–TGEKP–…–ZF8 (6 TGEKP linkers) │261–5 │
│ disorder │ confidently folded (pLDDT 90.6) │disord│
└──────────┴───────────────────────────────────────────────┴──────┘
▲ ▲ ▲
too short for encodes DNA SEQUENCE no folded
KRAB/BTB/SCAN; SPECIFICITY (−1,−4,−7 code) effector
not acidic (9.8%) NOT regulatory direction
What the array supports ─────────────► GO:0000981 (neutral TF) ✔ already curated (IBA)
What ProtNLM2 asserts ─────────────► GO:0001228 (ACTIVATOR) ✘ unsupported add-on
Equally plausible sibling ───────────► GO:0001227 (REPRESSOR) (KRAB-ZNF prior favors this)
Direct molecular function being tested: sequence-specific DNA binding by a tandem C2H2 array at RNA Pol II regulatory regions, and — the disputed part — the direction of the resulting transcriptional regulation.
This is a canonical case of over-specific computational annotation: a phylogenetic prior ("sequence-specific Pol II TF") is real, but the model has appended a directional qualifier that neither the domain architecture, the structure, nor any experiment justifies.
| # | Citation (PMID) | Evidence type | Supports/Refutes/Qualifies | Claim tested | Key finding | Context | Confidence / limits |
|---|---|---|---|---|---|---|---|
| 1 | 38754172 | Review / structural code | Refutes activator specificity | Does a C2H2 array encode regulatory direction? | The −1/−4/−7 recognition code specifies DNA base triplets (sequence), not activation/repression | Human/general C2H2-ZF | High for the general principle; not gene-specific |
| 2 | 25690854 | Review / large-scale assay | Refutes / qualifies | Is direction knowable for uncharacterized C2H2-ZFs? | "for most C2H2-ZF proteins it is unknown whether they even bind DNA or…to which sequences" | Human regulatory lexicon | High; establishes baseline uncertainty |
| 3 | UniProt A0A8J0SCI2 + InterPro/Pfam (database) | Sequence/domain (computational) | Refutes effector presence | Is there an effector domain? | Only C2H2/zf-C2H2 domains (IPR013087, IPR036236, PF00096×5, PTHR24381:SF440); N-term 36 aa; D+E = 9.8% | X. tropicalis protein record | High for absence of annotated effector; ProtNLM is itself computational |
| 4 | UniProt GO annotations (database, IBA) | Curated phylogenetic | Qualifies (competing, less specific) | What does curated evidence support? | Curated set stops at neutral GO:0000981; no activator term | GO_Central IBA | High; reflects community-standard call |
| 5 | AlphaFold AF-A0A8J0SCI2-F1 v6 (computed) | Structural (computational) | Refutes folded effector | Is there a structured activation module? | Only ZF core folded (pLDDT 90.6); flanks disordered (36.8 / 43.4) | AlphaFold DB | High for fold localization; disorder ≠ proof of no function |
| 6 | QuickGO ontology (computed) | Ontology structure | Qualifies | Is GO:0001228 stricter than GO:0000981? | GO:0001228 is a strict directional is_a child of GO:0000981 |
GO ontology | High; definitional |
| 7 | 42103097 | Mutant / mechanistic | Competing (repressor prior) | Are vertebrate C2H2-ZFs often repressors? | ZFP560, a KRAB-ZFP, represses chromatin via KAP1 recruitment | Mouse embryo | High for repressor precedent; different protein |
| 8 | 41668275 | Mechanistic | Competing (repressor prior) | " | KRAB-ZNF ZNF205 represses p53 targets | Human HCC | High for precedent; different protein |
| 9 | 41093942 | Mutant phenotype | Competing | " | PARIS/ZNF746, a KRAB-ZFP, is a transcriptional repressor | Mouse metabolism | High for precedent; different protein |
| 10 | 15623803 | Mutant phenotype | Competing | Direction of a Xenopus/zebrafish ZF factor | Prdm1/Blimp1 ZF protein is a repressor | Zebrafish / Xenopus | Different protein; direction varies and must be measured |
| 11 | 10777695 / 10842070 | Functional / expression | Competing | Direction of a Xenopus ZF factor | XSIP1 is a transcriptional repressor | Xenopus laevis | Different protein; direction is protein-specific |
| 12 | 14651851 | Functional | Qualifies | Can ZF factors be activators? | Churchill is a ZF transcriptional activator | Chick gastrula | Activators exist, but direction must be measured per-protein |
| 13 | 29146583 / 30155812 | Methods / motif atlas | Supports discriminating tests | How to obtain binding motifs | ChIP/motif and recognition-code methods can predict DNA targets | Human KRAB-ZNF / general | Orientation for follow-up experiments |
How the evidence base fits together. Two review-level sources (PMID: 38754172; PMID: 25690854) establish the governing principle: a C2H2 array encodes sequence specificity, and for most such proteins even the binding sequence is unknown — direction is never read out from the finger array. The computational provenance (UniProt/InterPro/Pfam domain content, N-terminal length and composition, and the AlphaFold per-region pLDDT profile) establishes the gene-specific fact: there is no effector domain in A0A8J0SCI2. The GO ontology query confirms that the disputed term differs from the supported one only by the added activator constraint. Finally, a cluster of vertebrate and Xenopus examples (ZFP560, ZNF205, PARIS/ZNF746, Prdm1/Blimp1, XSIP1 as repressors; Churchill as an activator) demonstrates that regulatory direction is protein-specific and must be measured, and that repression is at least as common a default for C2H2-ZFs — so an unsupported "activator" call is not merely uncertain but leans against the prior.
GO decision table
| Term | Type | Recommendation | Rationale |
|---|---|---|---|
| GO:0001228 activator, Pol II | MF | Reject / generalize → GO:0000981 | Direction not sequence-determinable; over-specific |
| GO:0000981 TF activity, Pol II (unspecified) | MF | Retain | Best-supported; matches IBA consensus |
| GO:0000978 cis-reg seq-specific DNA binding | MF | Retain | IBA, consistent with 8-finger array |
| GO:0001227 repressor, Pol II | MF | Do not add | No effector/repressor domain evidence either |
| GO:0006357 regulation of transcription by Pol II | BP | Retain | IBA; neutral direction |
| GO:0005634 nucleus | CC | Retain | IBA |
| GO:0008270 zinc ion binding | MF | Retain | IEA; consistent with C2H2 array |
| Gap | What was checked | Why it matters | What would resolve it |
|---|---|---|---|
| No experimental characterization of A0A8J0SCI2 | Literature search returned no primary data on this specific protein | Direction (activator/repressor) is only knowable by assay | Reporter/luciferase assay; effector-domain fusion tests |
| Unknown DNA-binding site / target genes | No ChIP/SELEX/PWM for this protein (checked JASPAR-relevant literature) | Even the neutral TF call rests on homology, not measured binding | ChIP-seq, ChIP-exo, or in-vitro SELEX; predicted PWM from recognition code |
| Disordered tails not functionally probed | AlphaFold shows disorder; composition not acidic | A cryptic disordered activation/repression domain cannot be fully excluded by composition alone | Domain-swap / tethering assays (e.g., Gal4-DBD fusions of the N/C tails) |
| Ortholog / paralog identity uncertain | PANTHER SF440; "XlCGF17.1-like" name | Correct ortholog assignment could import functional data if a characterized ortholog exists | Phylogenetic placement against characterized Xenopus/vertebrate ZF families |
| ProtNLM provenance opaque | Prediction is model-internal | Cannot audit why "activator" was chosen | Compare ProtNLM output across paralogs to detect systematic directional labeling |
A0A8J0SCI2 is an effector-less tandem C2H2 zinc-finger protein. Its finger array specifies DNA sequence recognition but carries no information about activation versus repression, and no effector domain (KRAB/BTB/SCAN/acidic) is present in sequence or in the AlphaFold structure. The curated phylogenetic evidence correctly stops at the direction-neutral term GO:0000981. The ProtNLM2 activator-specific prediction GO:0001228 is refuted as over-annotation and should not be added; direction remains experimentally undetermined, and if anything a repressor prior is at least as plausible for a vertebrate C2H2-ZF.